Douglas Earl Martin

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -37% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Douglas Earl Martin's trades of Allogene Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02
S Sale
65,104 -6.8%
481.23
US$3,418,038 		65,104 -6.8% 481.23 US$3,418,038
2026-02-02 2026-02-02
PrS Proposed sale
52,682
12.57
US$2,226,829 		52,682 12.57 US$2,226,829
2025-02-05 2025-02-03
S Sale
31,954 +3.3%
369.53
US$4,915,237 		31,954 +3.3% 369.53 US$4,915,237
2025-02-03 2025-02-03
PrS Proposed sale
6,404
1.71
US$10,951 		6,404 1.71 US$10,951
2024-08-21 2024-08-21
PrS Proposed sale
28,310
2.79
US$78,844 		28,310 2.79 US$78,844